GENIX
Price
$12.03
Change
-$0.24 (-1.96%)
Updated
Mar 10 closing price
Net Assets
317.82M
VMCIX
Price
$70.47
Change
-$1.44 (-2.00%)
Updated
Mar 10 closing price
Net Assets
181.84B
Ad is loading...

GENIX vs VMCIX

Header iconGENIX vs VMCIX Comparison
Open Charts GENIX vs VMCIXBanner chart's image
Gotham Enhanced Return Institutional
Price$12.03
Change-$0.24 (-1.96%)
VolumeN/A
Net Assets317.82M
Vanguard Mid Cap Index Institutional
Price$70.47
Change-$1.44 (-2.00%)
VolumeN/A
Net Assets181.84B
GENIX vs VMCIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GENIX vs. VMCIX commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GENIX is a Hold and VMCIX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VMCIX has more cash in the bank: 182B vs. GENIX (318M). VMCIX pays higher dividends than GENIX: VMCIX (1.46) vs GENIX (0.00). GENIX was incepted earlier than VMCIX: GENIX (12 years) vs VMCIX (27 years). GENIX (1.75) is less costly to investors than VMCIX (0.04). GENIX is a more actively managed with annual turnover of: 181.00 vs. VMCIX (13.00). GENIX has a lower initial minimum investment than VMCIX: GENIX (100000) vs VMCIX (5000000). VMCIX annual gain was more profitable for investors over the last year : 7.47 vs. GENIX (-6.48). VMCIX return over 5 years is better than : 64.64 vs. GENIX (23.37).
GENIXVMCIXGENIX / VMCIX
Total Expense Ratio1.500.043,750%
Annual Report Gross Expense Ratio1.750.044,375%
Fund Existence12 years27 years-
Gain YTD-0.728-0.415175%
Front LoadN/AN/A-
Min. Initial Investment10000050000002%
Min. Initial Investment IRAN/AN/A-
Net Assets318M182B0%
Annual Yield % from dividends0.001.46-
Returns for 1 year-6.487.47-87%
Returns for 3 years13.3020.0066%
Returns for 5 years23.3764.6436%
Returns for 10 years-0.90114.09-1%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FLGT18.590.69
+3.85%
Fulgent Genetics
RVTY117.564.35
+3.84%
Revvity
CPRX21.960.29
+1.34%
Catalyst Pharmaceuticals
DOUG1.710.01
+0.59%
Douglas Elliman
BURU0.19-0.02
-7.97%
Nuburu Inc.